IP Verse

Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof - EP3061454

The patent EP3061454 was granted to Boehringer Ingelheim Animal Health USA on Mar 10, 2021. The application was originally filed on Jan 31, 2013 under application number EP16163407A. The patent is currently recorded with a legal status of "Revoked".

EP3061454

BOEHRINGER INGELHEIM ANIMAL HEALTH USA
Application Number
EP16163407A
Filing Date
Jan 31, 2013
Status
Revoked
Aug 19, 2022
Grant Date
Mar 10, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

NISSAN CHEMICALDec 10, 2021DOMPATENT VON KREISLER SELTING WERNERADMISSIBLE
NISSAN CHEMICALDec 10, 2021DOMPATENT VON PATENT UND RECHTSANWALTENADMISSIBLE
KRKADec 9, 2021KUTZENBERGER WOLFF & PARTNERADMISSIBLE

Patent Citations (184) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0002916
DESCRIPTIONEP0007812
DESCRIPTIONEP0179022
DESCRIPTIONEP0667054
DESCRIPTIONEP0677054
DESCRIPTIONEP0892060
DESCRIPTIONGB1390336
DESCRIPTIONGB2140010
DESCRIPTIONNZ237086
DESCRIPTIONUS2004037869
DESCRIPTIONUS2004151759
DESCRIPTIONUS2009143410
DESCRIPTIONUS2010069247
DESCRIPTIONUS2010137372
DESCRIPTIONUS2010137612
DESCRIPTIONUS2010179194
DESCRIPTIONUS2010179195
DESCRIPTIONUS2010197624
DESCRIPTIONUS2010254959
DESCRIPTIONUS2010254960
DESCRIPTIONUS2011059988
DESCRIPTIONUS2011086886
DESCRIPTIONUS2011118212
DESCRIPTIONUS2011144349
DESCRIPTIONUS2011152081
DESCRIPTIONUS2011152312
DESCRIPTIONUS2011159107
DESCRIPTIONUS2011166193
DESCRIPTIONUS2011245239
DESCRIPTIONUS2011245274
DESCRIPTIONUS2011251247
DESCRIPTIONUS2012015946
DESCRIPTIONUS2012030841
DESCRIPTIONUS2012035122
DESCRIPTIONUS2012077765
DESCRIPTIONUS2012232026
DESCRIPTIONUS2012238517
DESCRIPTIONUS2012309620
DESCRIPTIONUS3486186
DESCRIPTIONUS3748356
DESCRIPTIONUS3818047
DESCRIPTIONUS3887964
DESCRIPTIONUS3950360
DESCRIPTIONUS3952478
DESCRIPTIONUS4054967
DESCRIPTIONUS4097961
DESCRIPTIONUS4134973
DESCRIPTIONUS4182003
DESCRIPTIONUS4199569
DESCRIPTIONUS4225598
DESCRIPTIONUS4284652
DESCRIPTIONUS4310519
DESCRIPTIONUS4327076
DESCRIPTIONUS4334339
DESCRIPTIONUS4338702
DESCRIPTIONUS4343068
DESCRIPTIONUS4356595
DESCRIPTIONUS4372008
DESCRIPTIONUS4427663
DESCRIPTIONUS4468390
DESCRIPTIONUS4523520
DESCRIPTIONUS4535505
DESCRIPTIONUS4597135
DESCRIPTIONUS4608731
DESCRIPTIONUS4609543
DESCRIPTIONUS4622717
DESCRIPTIONUS4697308
DESCRIPTIONUS4742060
DESCRIPTIONUS4751225
DESCRIPTIONUS4768941
DESCRIPTIONUS4780931
DESCRIPTIONUS4798837
DESCRIPTIONUS4818446
DESCRIPTIONUS4821376
DESCRIPTIONUS4855317
DESCRIPTIONUS4859657
DESCRIPTIONUS4871719
DESCRIPTIONUS4872241
DESCRIPTIONUS4874749
DESCRIPTIONUS4920148
DESCRIPTIONUS4935243
DESCRIPTIONUS4963582
DESCRIPTIONUS4973711
DESCRIPTIONUS4975039
DESCRIPTIONUS4978677
DESCRIPTIONUS4996743
DESCRIPTIONUS5021025
DESCRIPTIONUS5022888
DESCRIPTIONUS5055596
DESCRIPTIONUS5077308
DESCRIPTIONUS5165218
DESCRIPTIONUS5202242
DESCRIPTIONUS5399582
DESCRIPTIONUS5496931
DESCRIPTIONUS5571901
DESCRIPTIONUS5591606
DESCRIPTIONUS5631155
DESCRIPTIONUS5655436
DESCRIPTIONUS5670364
DESCRIPTIONUS5670486
DESCRIPTIONUS5703078
DESCRIPTIONUS5735603
DESCRIPTIONUS5750548
DESCRIPTIONUS5750695
DESCRIPTIONUS5753255
DESCRIPTIONUS5767253
DESCRIPTIONUS5824653
DESCRIPTIONUS5827565
DESCRIPTIONUS5840861
DESCRIPTIONUS5962499
DESCRIPTIONUS5980228
DESCRIPTIONUS6001384
DESCRIPTIONUS6001981
DESCRIPTIONUS6010710
DESCRIPTIONUS6060078
DESCRIPTIONUS6083519
DESCRIPTIONUS6086940
DESCRIPTIONUS6093427
DESCRIPTIONUS6093441
DESCRIPTIONUS6096329
DESCRIPTIONUS6110521
DESCRIPTIONUS6159516
DESCRIPTIONUS6174540
DESCRIPTIONUS6221894
DESCRIPTIONUS6270790
DESCRIPTIONUS6387381
DESCRIPTIONUS6399786
DESCRIPTIONUS6498153
DESCRIPTIONUS6685954
DESCRIPTIONUS6998131
DESCRIPTIONUS7084280
DESCRIPTIONUS7662972
DESCRIPTIONUS7759381
DESCRIPTIONUS7780931
DESCRIPTIONUS7897630
DESCRIPTIONUS7947715
DESCRIPTIONUS7951828
DESCRIPTIONUS7955632
DESCRIPTIONUS7964621
DESCRIPTIONUS8053452
DESCRIPTIONUS8088801
DESCRIPTIONUS8119671
DESCRIPTIONUS8318757
DESCRIPTIONWO0176370
DESCRIPTIONWO2004016252
DESCRIPTIONWO2005062782
DESCRIPTIONWO2007123855
DESCRIPTIONWO2007125984
DESCRIPTIONWO2009002451
DESCRIPTIONWO2009004432
DESCRIPTIONWO2011075591
DESCRIPTIONWO2011104087
DESCRIPTIONWO2011104088
DESCRIPTIONWO2011104089
DESCRIPTIONWO2011154433
DESCRIPTIONWO2011154434
DESCRIPTIONWO2011157748
DESCRIPTIONWO2012086462
DESCRIPTIONWO2012089622
DESCRIPTIONWO2012089623
DESCRIPTIONWO2012107533
DESCRIPTIONWO2012120135
DESCRIPTIONWO9109961
DESCRIPTIONWO9222555
DESCRIPTIONWO9703988
OPPOSITIONUS2004037869
OPPOSITIONUS2004151759
OPPOSITIONUS2006222684
OPPOSITIONUS61595463
OPPOSITIONWO2004014143
OPPOSITIONWO2005099692
OPPOSITIONWO2007067582
OPPOSITIONWO2008148027
OPPOSITIONWO2008154528
OPPOSITIONWO2009002809
OPPOSITIONWO2009024541
OPPOSITIONWO2009064859
OPPOSITIONWO2011149749
OPPOSITIONWO2013119442
OPPOSITIONWO2013150052
OPPOSITIONWO2014079825
SEARCHWO2008154528
SEARCHWO2009002809
SEARCHWO2011149749

Non-Patent Literature (NPL) Citations (26) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ALBERS-SCHONBERG, "Avermectins Structure Determination", J. AM. CHEM. SOC., (1981), vol. 103, pages 4216 - 4221
DESCRIPTION- DAVIES H.G ET AL., "Avermectins and Milbemycins", NAT. PROD. REP., (1986), vol. 3, pages 87 - 121
DESCRIPTION- FASINU ET AL., BIOPHARM. DRUG DISPOS., (2011), vol. 32, pages 1185 - 209
DESCRIPTION- "International Nonproprietary Names for Pharmaceutical Substances (INN", WHO DRUG INFORMATION, (2003), vol. 17, no. 4, pages 263 - 286
DESCRIPTION- J. ANTIBIOTICS, (1990), vol. 43, page 1380
DESCRIPTION- J. ANTIBIOTICS, (1991), vol. 44, page 492
DESCRIPTION- J. CHEM. SOC. - CHEM. CO»I>N, (1980), page 601
DESCRIPTION- KAMINSKY ET AL., NATURE, (20080313), vol. 452, pages 176 - 181
DESCRIPTION- MROZIK H ET AL., "Synthesis of Milbemycins from Avermectins", TETRAHEDRON LETT., (1983), vol. 24, pages 5333 - 5336
DESCRIPTION- OSTLIND ET AL., MEDICAL AND VETERINMY ENTOMOLOGY, (1997), vol. 11, pages 407 - 408
DESCRIPTION- OSTLIND ET AL., RESEARCH IN VETERINARY SCIENCE, (1990), vol. 48, pages 260 - 61
DESCRIPTION- SAGER ET AL., VETERINARY PARASITOLOGY, (2009), vol. 159, pages 49 - 54
DESCRIPTION- SALGADO V.L.; SPARKS T.C., "The Spinosyn.s: Chemistry, Biochetraistry, Mode ofAction, and Resistance", COMPREHENSIVE MOLECULAR INSECT SCIENCE, (2005), vol. 6, pages 137 - 173
DESCRIPTION- TET. LETT., (1981), vol. 22, page 1977
DESCRIPTION- TETT. LETT, (1981), vol. 22, page 135
DESCRIPTION- VETERINARY PARASITOLOGY, (199307), vol. 49, no. 1, pages 5 - 15
DESCRIPTION- V. HAYDEN ET AL., "The Road Map to Oral Bioavailability: an Industrial Perspective", EXPERT OPIN. DRUG VLETAB. TOXICOL., (2006), vol. 2, no. 4, pages 591 - 608
DESCRIPTION- WILSON ET AL., PARASITOLOGY, (200301), vol. 126, pages 79 - 86
OPPOSITION- Alexander T. Florence, Juergen Siepmann, Modern Pharmaceutics, 5th ed., (20090101), vol. 2: Applications and Advances, pages 305 - 308, XP055879101
OPPOSITION- Anonymous, "SUMMARY OF PRODUCT CHARACTERISTICS", SPC Plerion 5, (20090414), vol. 09, no. 1, pages 1 - 4, XP055909842
OPPOSITION- Brewster M. E., Augustijns P., "Solvent Systems and Their Selection in Pharmaceutics and Biopharmaceutics", Biotechnology: Pharmaceutical Aspects, (20070101), pages 1 - 129, XP055865157
OPPOSITION- Larry L. Augsburger, Stephen W. Hoag, Pharmaceutical Dosage Forms: Tablets, Third Edition, (2008), vol. 2: Rational Design and Formulation, pages 383 - 406, XP055256116
OPPOSITION- Liu, Water-Insoluble Drug Formulation, 2nd ed., (20080101), pages 255 - 263, 267 - 268, 273, 274, XP055879107
OPPOSITION- Rathbone Michael J., Arlene Mcdowell, Long Acting Animal Health Drug Products - Fundamentals and Applications, (20121011), pages 23 - 25, 165 - 167, XP055879080
OPPOSITION- Rowe Raymond C., Sheskey Paul J., Quinn Marian E.,, "Handbook of Pharmaceutical Excipients", Pharmaceutical Press, (20090414), pages 1 - 765, URL: https://jums.ac.ir/dorsapax/Data/sub_7/file/Handbook%20of%20pharmaceutical%20excipients.pdf
OTHER- MERCK, "13,64% w/w CBPI Flavored Chewable Tablet for Dogs", Material Safety Data Sheet, (20110624), pages 1 - 7, XP055605561

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents